首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines
【24h】

Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines

机译:基因组 - 宽的B细胞,CD4(+)和CD8(+)T细胞表位,其在人和动物冠状病毒之间高度保守,从SARS-COV-2鉴定为先发制人泛冠状病毒疫苗的靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Over the last two decades, there have been three deadly human outbreaks of coronaviruses (CoVs) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2, which has caused the current COVID-19 global pandemic. All three deadly CoVs originated from bats and transmitted to humans via various intermediate animal reservoirs. It remains highly possible that other global COVID pandemics will emerge in the coming years caused by yet another spillover of a bat-derived SARS-like coronavirus (SL-CoV) into humans. Determining the Ag and the human B cells, CD4(+) and CD8(+) T cell epitope landscapes that are conserved among human and animal coronaviruses should inform in the development of future pan-coronavirus vaccines. In the current study, using several immunoinformatics and sequence alignment approaches, we identified several human B cell and CD4(+) and CD8(+) T cell epitopes that are highly conserved in 1) greater than 81,000 SARS-CoV-2 genome sequences identified in 190 countries on six continents; 2) six circulating CoVs that caused previous human outbreaks of the common cold; 3) nine SL-CoVs isolated from bats; 4) nine SL-CoV isolated from pangolins; 5) three SL-CoVs isolated from civet cats; and 6) four MERS strains isolated from camels. Furthermore, the identified epitopes: 1) recalled B cells and CD4(+) and CD8(+) T cells from both COVID-19 patients and healthy individuals who were never exposed to SARS-CoV-2, and 2) induced strong B cell and T cell responses in humanized HLA-DR1/HLA-A*02:01 double-transgenic mice. The findings pave the way to develop a preemptive multiepitope pancoronavirus vaccine to protect against past, current, and future outbreaks.
机译:2019冠状病毒疾病、冠状病毒、沙门氏病毒三型引起的冠状病毒(COVs)的致死性爆发,已引起了全球COVID-19型流感大流行。这三种致命的冠状病毒都起源于蝙蝠,并通过各种中间动物宿主传播给人类。由于蝙蝠衍生的SARS样冠状病毒(SL-CoV)再次蔓延到人类,在未来几年内,其他全球新冠疫情仍极有可能出现。确定人类和动物冠状病毒中保存的Ag和人类B细胞、CD4(+)和CD8(+)T细胞表位景观,应为未来泛冠状病毒疫苗的开发提供信息。在目前的研究中,我们使用多种免疫信息学和序列比对方法,确定了几个人类B细胞和CD4(+)和CD8(+)T细胞表位,这些表位高度保守,1)在六大洲190个国家中确定的SARS-CoV-2基因组序列超过81000个;2) 六种循环冠状病毒曾导致人类爆发普通感冒;3) 从蝙蝠中分离出9株SL冠状病毒;4) 从穿山甲中分离到9株SL冠状病毒;5) 从果子狸中分离出三种SL冠状病毒;6)从骆驼中分离的四株MERS菌株。此外,2019冠状病毒疾病的识别表位:1)从COSID-19患者和健康人中从未暴露于SARS COV-2的B细胞和CD4(+)和CD8(+)T细胞,2)在人源化的HLA-DR1/HLA-A*0201双转基因小鼠中诱导了强B细胞和T细胞应答。这些发现为开发一种先发制人的多表位全冠状病毒疫苗铺平了道路,以预防过去、现在和未来的疫情。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号